drugset / Trial / NCT00002786
Biological Therapy in Treating Patients With Metastatic Melanoma
Phase 1/2
Completed
20 enrolled
Fred Hutchinson Cancer Center
National Cancer Institute (NCI) · collab
Treatment
Summary
RATIONALE: Biological therapies use different ways to stimulate the immune system and stop cancer cells from growing. PURPOSE: Phase I/II trial to study the effectiveness of biological therapy in treating patients who have metastatic melanoma.
Timeline
- Start
- 1995-10
- Primary completion
- —
- Completion
- 2006-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Tumor Infiltrating Lymphocytes | Cell therapy | — | — |
| Background | aldesleukin | Protein / enzyme biologic | — | Subcutaneous |